NIH StrokeNet Network Standard Operating Procedure

Size: px
Start display at page:

Download "NIH StrokeNet Network Standard Operating Procedure"

Transcription

1 1. PURPOSE The purpose of this SOP is to outline procedures for Institutional Review Board (IRB) approval and oversight of National Institutes of Health (NIH) StrokeNet affiliated protocols conducted by Department of Veterans Affairs (VA) Facilities. The VA Central IRB (VA CIRB) will serve as the IRB of Record for VA Facilities conducting NIH StrokeNet affiliated protocols. The VA CIRB will collaborate with the National Coordinating Center (NCC), the National Data Management Center (NDMC), and the StrokeNet Central Institutional Review Board (StrokeNet CIRB). 2. DEFINITIONS AND ACRONYMS National Coordinating Center (NCC) -An institution designed and directly funded by NINDS/NIH to oversee project management for NIH StrokeNet research protocols. The NCC for NIH StrokeNet is located at the University of Cincinnati. NCC Project Manager - The individual responsible for being the interface with StrokeNet CIRB liaison, the VA Protocol Principal Investigator (VA PPI), and VA Local Site Investigators (LSI) for all-va Facilities participating in a specific StrokeNet protocol. This includes approvals and modifications of new protocols, protocol modifications, local site submissions, continuing reviews, and reporting of unanticipated problems involving risks to subjects or others, SAEs, and protocol deviations. National Data Management Center (NDMC) - An institution designed and directly funded by NINDS/NIH to oversee all aspects of data collection and management for NIH StrokeNet research protocols. The NDMC for NIH StrokeNet is located at the Medical University of South Carolina (MUSC), Charleston, NC. National Institutes of Health (NIH) StrokeNet - The National Institute of Neurological Disorders and Stroke (NINDS) established the NIH StrokeNet to facilitate the rapid initiation and efficient implementation of small and large multisite exploratory and confirmatory clinical trials focused on promising interventions for stroke prevention, treatment, and recovery, as well as validation studies of biomarkers or outcome measures. The main components include the National Coordinating Center (NCC) at the University of Cincinnati, the National Data Management Center (NDMC) at the Medical University of South Carolina, and 25 academic regional coordinating centers (RCCs) across the United States. NIH StrokeNet Central Institutional Review Board (StrokeNet CIRB) - An IRB designed and directly funded by NINDS/NIH to oversee human subject research for NIH StrokeNet research protocols. The StrokeNet CIRB serves as the IRB of Record for non-va sites. The StrokeNet CIRB is operated and managed at the ADM 23 Final v1.0 Page 1 of 8

2 University of Cincinnati and will provide IRB oversight for all non-exempt human subject research activities for non-va sites. Protocol Principal Investigator (PPI) - The investigator at the prime award site who was awarded funding for the execution of the NIH StrokeNet research protocol. The PPI is responsible for the development of the prime award protocol and the coordination of the conduct of the research at multiple performance sites, including required regulatory reporting to the VA CIRB through the VA investigators. For purposes of StrokeNet, the PPI is also considered the sponsor for all FDA and DSMB activities. If this person is the IND or IDE holder, this individual is also responsible for all applicable FDA regulatory requirements, which includes all Sponsor-Investigator responsibilities. The PPI may be from a VA or non-va institution. Performance site - A site at which the prime award protocol is performed. Prime Award Site - The institution that is awarded the grant to oversee the study protocol Prime Award Protocol - Protocol for the multi-site clinical trial submitted by the PPI that is initially approved by the StrokeNet CIRB and VA CIRB. (SOP) - established or prescribed methods to be followed routinely for the performance of designated operations or in designated situations. StrokeNet CIRB Liaison - The StrokeNet CIRB Liaison coordinates communications between the StrokeNet CIRB and StrokeNet research sites. StrokeNet /VA Site Coordination Team - The Chairs of the VA CIRB and the StrokeNet CIRB as well as the VA CIRB administrator, StrokeNet CIRB Liaison, and the NCC Project Manager VA Central Office Institutional Review Board (VA CIRB) - The central IRB supported by the VHA Office of Research and Development that has authority for oversight of VA human subjects studies it approves. VA CIRB Administrator -The VA CIRB Administrator is responsible for overseeing the daily administrative activities of the VA CIRB. VA Office of Research and Development (ORD) - is the office within VHA that is has primary responsibility for developing the policies involving the conduct of research at VA Facilities as well being ADM 23 Final v1.0 Page 2 of 8

3 responsible for the intramural VA research program. ORD consists of the following four research services: Biomedical Laboratory Research & Development Service Clinical Science Research & Development Service, which includes the Cooperative Studies Program (CSP) Health Services Research & Development Service Rehabilitation Research & Development Service ORD also include different program offices that support VA research. This includes the Program for Research Integrity, Development, and Education (PRIDE), which is responsible for the operation of the VA CIRB VA-Local Site Investigator (LSI) - The Local Site Investigator (LSI) is a VA qualified investigator at a site participating in a multi-site research project. The LSI oversees scientific, technical, and day-to-day management of the research at the performance site. The VA Protocol Principal Investigator is not analogous to a LSI, but a LSI can also be the VA Protocol Principal Investigator for a StrokeNet protocol. The LSI responsibilities are described in VHA Handbook and in VA Central IRB SOPs. The VA Central IRB SOPs are available for reference on the VA Central IRB website VA Protocol Principal Investigator (VA PPI) - A VA Investigator designated as the overall PI for all VA Facilities participating in a specific StrokeNet protocol. The VA PPI is not analogous to a LSI. The VA PPI and the National Study Coordinator serve as the main points of contact on the study team for the VA CIRB regarding activities involving the overall project. The PPI responsibilities are described in VHA Handbook and in VA Central IRB SOPs. The VA Central IRB SOPs are available for reference on the VA Central IRB website WebDCU - An integrated web-based clinical trial management system (CTMS) developed by NDMC for clinical trial data management and full scope trial operation management. ADM 23 Final v1.0 Page 3 of 8

4 3. SCOPE The VA CIRB and StrokeNet CIRB are two central IRBs. The VA CIRB is part of the VHA Central Office Human Research Protection Program (HRPP) in Washington, DC. The StrokeNet CIRB is part of the HRPP at the University of Cincinnati in Cincinnati, OH. The VA CIRB is the IRB of Record for all VA Facilities conducting StrokeNet studies, including the Cincinnati VA. The StrokeNet CIRB is the IRB of Record for all non-va Facilities conducting StrokeNet studies. This SOP applies to the coordination of activities that involves obtaining VA CIRB review and approval of StrokeNet studies conducted by VA Facilities in conjunction with the StrokeNet CIRB review and approval of StrokeNet studies conducted by non-va Facilities. 4. Roles of StrokeNet NCC and NDMC A. Role of the NCC 1. Establishing a VA PI for NIH StrokeNet Trials conducted at VA facilities All StrokeNet research projects involve a prime award protocol that is submitted by the PPI. The prime award protocol is approved for conduct at multiple performance sites. If VA Facilities are included as performance sites in a StrokeNet research project, a VA PI must be designated as a VA PPI prior to preparing application submission materials to the VA CIRB and designating VA LSIs. If the PPI is not a VA Investigator, the NCC will assist the PPI in identifying and establishing a VA Investigator as the VA PPI for the study. This individual will serve as a co-ppi. If the PPI is a VA Investigator, a PPI will also be designated for the non-va Facilities prior to preparing application submission materials to the StrokeNet CIRB and designating non-va participating LSIs. This individual will serve as a co-ppi. 2. Assist VA PI with preparing a New Project Application to the VA CIRB The NCC project manager will assist the VA PPI in completing VA CIRB forms and documents. The VA PPI will submit the required forms and associated documents to the VA CIRB per VA CIRB procedures to the VA CIRB SharePoint site. 3. Assist with submission of Local Site Investigator (LSI) Applications ADM 23 Final v1.0 Page 4 of 8

5 The NCC project manager will review and assist the VA LSI to complete VA CIRB forms and documents. The LSI will submit the completed forms to the VA PPI for review prior to upload to the VA CIRB SharePoint site. The VA PPI will not be responsible for submitting VA LSI applications to the VA CIRB; the LSI is responsible for uploading LSI applications. 4. Assist with submission of requests to amend or modify an approved project The NCC project manager will assist the VA PPI or LSI to complete the VA CIRB forms and documents. The VA PPI or LSI will upload the completed forms to the VA CIRB SharePoint site depending upon whether the amendment or modification involves the prime award protocol or modifications/amendments to the local conduct of the project (i.e., modification to an informed consent document involving changes to the local research team s contact information). 5. Assist with submission of Continuing Reviews The NCC project manager will assist the LSI or the LS study coordinator to complete VA CIRB Continuing Review Form prior to review and submission of the materials by the VA PPI. The VA PPI is responsible for submitting continuing review applications from all participating LSIs as well as completing an overall continuing review submission for the study. 6. Assist with Reporting of Serious Adverse Events and Unanticipated Problems The NCC project manager will assist the VA PPI in collecting data from the sites; reporting serious adverse events and unanticipated problems involving risks to subjects or others that require reporting to the VA CIRB in accordance with VHA Handbook and VA Central IRB SOPs. B. Role of the NDMC The NDMC is responsible for providing the WebDCU CTMS for all NIH StrokeNet trials. This system houses and manages the necessary regulatory documents collected for the trial execution and houses the trial data entered by each site participating in the trial. This system also tracks all protocol required, site reported adverse events and unanticipated problems. All VA Facilities participating in StrokeNet studies must sign a data use agreement (DUA) with NDMC describing the data being sent to and received from the NDMC as part of StrokeNet activities (see attachment B). The DUA is executed by the VA Facility authorized signatory (either the authorized Medical Center Director or the authorized Associate Chief of Staff for Research & Development). This ADM 23 Final v1.0 Page 5 of 8

6 document should be printed, signed by the appropriate VA Facility authorized signatory, and uploaded into the WebDCU Regulatory Document Module. This document will apply for all StrokeNet studies conducted at the facility and will be archived in the StrokeNet CTMS. 5. Coordinated CIRB Review of Prime Award Procedure A. For StrokeNet Studies in which VA Facilities are identified prior to the initial IRB approval of the prime award protocol: Prior to review of the prime award protocol by each respective CIRB, the StrokeNet/VA Site Coordination Team will conduct a pre-review of the submitted materials and communicate in writing or orally issues that could affect CIRB review and approval. This pre-review is not to be interpreted as an expedited IRB review process as described in 45 CFR (b) and 38 CFR (b) and does not take the place of IRB review procedures required for IRB approval of research. Following resolution of any issues identified by the StrokeNet/VA Site Coordination Team review, the StrokeNet IRB application materials will be submitted, if possible, within the same week for VA facilities and non-va Facilities to the VA CIRB and the StrokeNet CIRB. The VA CIRB and StrokeNet CIRB Chairs, the VA CIRB administrator, and the StrokeNet CIRB liaison will communicate during this process to discuss any significant discrepancies between the IRB reviews. 6. For StrokeNet Studies in which VA Facilities are identified after the StrokeNet CIRB approval of the prime award protocol: If VA facilities are identified as research sites after the StrokeNet CIRB approves the prime award protocol, the VA CIRB will review the prime award protocol most recently approved by the StrokeNet CIRB. The VA PPI will submit the protocol to the VA CIRB by the VA PPI. The VA CIRB must approve the protocol before it reviews and approves the VA LSI applications. If the VA CIRB identifies issues during the review that affect the approval process, the VA CIRB Chairs may communicate those issues with the StrokeNet CIRB Chair. 7. For StrokeNet Studies in which non-va Facilities are identified after the VA CIRB approval of the prime award protocol: If non-va facilities are identified as research sites after the VA CIRB approves the prime award protocol, the StrokeNet CIRB will review the prime award protocol most recently approved by the VA CIRB as submitted by the VA PPI. If the StrokeNet CIRB identifies issues during the review that affect the approval process, the StrokeNet CIRB Chair may communicate those issues with the VA CIRB Chairs. ADM 23 Final v1.0 Page 6 of 8

7 8. APPLICABLE REGULATIONS AND GUIDELINES 21 CFR Part 50, Protection of Human Subjects 21 CFR Part 56, IRBs 38 CFR Part 16, Protection of Human Subjects Final NIH Policy on the Use of a Single Institutional Review Board for Multi Site Research VHA Handbook (Research Compliance Reporting Requirements issued June 15, 2015) VHA Handbook (Requirements for the Protection of Human Subjects in Research issued November 12, 2014) 9. REFERENCES TO OTHER APPLICABLE SOPS VA CIRB SOPs are available at StrokeNet CIRB SOPs are available at ATTACHMENTS A. Memorandum of Understanding (MOU) between Veterans Health Administration and University of Cincinnati on behalf of Its Institutional Review Board B. Research Data Use Agreement Template between VA facilities and the NDMC ADM 23 Final v1.0 Page 7 of 8

8 11. DOCUMENT HISTORY Version Description of Modification Completion Date Issue Date Effective Date 1.0 FINAL 30-Nov Jan Jan-2017 ADM 23 Final v1.0 Page 8 of 8

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB Page: 1 of 5 I. PURPOSE II. III. IV. To provide guidance on the types of research activities that are subject to review and approval by the Committees for the Protection of Human, which comprise the Institutional

More information

Human Research Protection Program Institutional Review Board Procedure

Human Research Protection Program Institutional Review Board Procedure Page 1 of 10 DESCRIPTION INSTITUTIONAL REVIEW BOARD REVIEW OF RESEARCH INVOLVING PRISONERS Prisoners may be under constraints because of their incarceration that could affect their ability to make a truly

More information

1. Comply with the NCI CIRB s requirements and directives;

1. Comply with the NCI CIRB s requirements and directives; Michigan State University Human Research Protection Program Subject: Use of the National Cancer Institute Central Institutional Review Board Section: 1-5 This policy and procedure supersedes those previously

More information

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 1. Introduction The St. Michael s Hospital (SMH) REB

More information

MOST Clinical Performing Site Study Drug Procedures

MOST Clinical Performing Site Study Drug Procedures Abbreviations and Definitions MOST Clinical Performing Site Study Drug Procedures ACS AIS Arm Acute Coronary Syndrome Acute Ischemic Stroke Argatroban (100µg/kg bolus and a 12-hour infusion at 3µg/kg/min)

More information

TITLE: Obtaining Informed Consent of Non-English Speakers SOP #: CON-101 (formerly SM-507) Page: 1 of 7 Effective Date: 1/14/2016

TITLE: Obtaining Informed Consent of Non-English Speakers SOP #: CON-101 (formerly SM-507) Page: 1 of 7 Effective Date: 1/14/2016 SOP #: CON-101 (formerly SM-507) Page: 1 of 7 Effective Date: 1. POLICY STATEMENT: All informed consent information (initial or updates for new information) must be presented in a language that is understandable

More information

StrokeNet: Rationale, Overview, Objectives, Priorities, Status. Joe Broderick Yuko Palesch

StrokeNet: Rationale, Overview, Objectives, Priorities, Status. Joe Broderick Yuko Palesch StrokeNet: Rationale, Overview, Objectives, Priorities, Status Joe Broderick Yuko Palesch NIH StrokeNet Overview NINDS created StrokeNet in late 2013 (fully funded in 4/2014) to prioritize, harmonize,

More information

VA Funding Opportunities & Research Resources

VA Funding Opportunities & Research Resources VA Funding Opportunities & Research Resources Frederick G. Hamel, Ph.D. Acting Associate Chief of Staff/Research Professor Internal Medicine and Pharmacology/ UNMC October 19, 2015 NWI Way Contacts If

More information

NCI CIRB Independent Model studies is described herein.

NCI CIRB Independent Model studies is described herein. Review for Studies Approved by the Independent Model National Cancer Institute (NCI) Pediatric Central Institutional (Formerly entitled Facilitated IRB Review for Studies Approved by the National Cancer

More information

ALS ACT (Accelerated Therapeutics)

ALS ACT (Accelerated Therapeutics) ALS ACT (Accelerated Therapeutics) Request for Proposals: Phase II Clinical development of novel, high-potential treatments for people with ALS Release Date 23 October 2015 Letter of intent due: November

More information

Stephen C. Joseph, M.D., M.P.H.

Stephen C. Joseph, M.D., M.P.H. MAR 05 1996 MEMORANDUM FOR: ASSISTANT SECRETARY OF THE ARMY (M&RA) ASSISTANT SECRETARY OF THE NAVY (M&RA) ASSISTANT SECRETARY OF THE AIR FORCE (MRAI&E) SUBJECT: DoD Participation in Clinical Cancer Trials

More information

Guidance - IDE Early/Expanded Access for Devices

Guidance - IDE Early/Expanded Access for Devices Guidance - IDE Early/Expanded Access for Devices An unapproved medical device may normally only be used on human subjects through an approved clinical study in which the subjects meet certain criteria

More information

Identification & Diagnosis of Cryptogenic Stroke What is NINDS/role

Identification & Diagnosis of Cryptogenic Stroke What is NINDS/role Identification & Diagnosis of Cryptogenic Stroke What is NINDS/role October 9, 2015 Scott Janis, Ph.D. Program Director, National Institute of Neurological Disorders and Stroke, The National Institute

More information

Protection of Research Subjects: The IRB Process

Protection of Research Subjects: The IRB Process Protection of Research Subjects: The IRB Process Ethics in Patient-Oriented Research October 13, 2010 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Conducting Risk and Benefit Assessments

More information

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose

More information

Highlights - In this issue...

Highlights - In this issue... Journal for Clinical Research Excellence Issue 70 A Publication of the Society of Clinical Research Associates November 2011 530 West Butler Avenue, Suite 109 Chalfont, PA 18914 USA ISSN 1536-9900 Highlights

More information

IRB Red Flags How to Know When IRB Review May Be Needed

IRB Red Flags How to Know When IRB Review May Be Needed IRB Red Flags How to Know When IRB Review May Be Needed Human Research Protection Program Presented by Catherine Higgins, Ph.D., CIP, CIM HRPP Director Historical Ethical Atrocities Tuskegee Syphilis Study

More information

New NCCIH Funding Opportunities for Mind and Body Clinical Trials. April 24, 2017

New NCCIH Funding Opportunities for Mind and Body Clinical Trials. April 24, 2017 New NCCIH Funding Opportunities for Mind and Body Clinical Trials April 24, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H. Branch Chief, Clinical Research in Complementary and Integrative Health Branch,

More information

Human Subjects Research: Overview. Colleen Kohashi and Tani Prestage Office for the Protection of Human Subjects (OPHS) February 26, 2016

Human Subjects Research: Overview. Colleen Kohashi and Tani Prestage Office for the Protection of Human Subjects (OPHS) February 26, 2016 Human Subjects Research: Overview Colleen Kohashi and Tani Prestage Office for the Protection of Human Subjects (OPHS) February 26, 2016 Topics to be Covered Am I doing human subjects research?; Risk determinations

More information

TENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE

TENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE TENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE RESEARCH PROPOSAL FORM This proposal is: (check where applicable) Dissertation Research: Grant Proposal: Funding Agency: Master's Thesis Research: Faculty

More information

Office of Research Compliance. Research Involving Human Subjects

Office of Research Compliance. Research Involving Human Subjects Office of Research Compliance Research Involving Human Subjects Office of Research Compliance Three FTE and one student worker Facilitate the IACUC We are not the IRB or the IACUC Best way to contact us

More information

COMMON RULE 2019 IMPLEMENTATION DATE: JANUARY 21, 2019

COMMON RULE 2019 IMPLEMENTATION DATE: JANUARY 21, 2019 COMMON RULE 2019 IMPLEMENTATION DATE: JANUARY 21, 2019 HISTORY The Common Rule has been in effect since 1991, and was adopted by 15 federal departments and agencies, including the Department of Health

More information

National Cancer Institute Clinical Trial Cooperative Groups

National Cancer Institute Clinical Trial Cooperative Groups National Cancer Institute Clinical Trial Cooperative Groups Perspectives from the National Surgical Adjuvant Breast and Bowel Project Joyce Mull, MPM Director, Regulatory Affairs NSABP Foundation, Inc.

More information

IRB consortia as an approach to facilitating effective and efficient reviews

IRB consortia as an approach to facilitating effective and efficient reviews Washington University School of Medicine Digital Commons@Becker Human Research Protection Program (HRPP) Education Human Research Protection Office 2008 IRB consortia as an approach to facilitating effective

More information

SALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS

SALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS SALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS If you have a full committee review: 1. Your proposal must be submitted at minimum 14 days before the

More information

Division of Research University Policy

Division of Research University Policy Division of Research University Policy SUBJECT: Effective Date: Policy Number: SATELLITE ANIMAL HOUSING FACILITIES June 24, 2016 Supersedes: August 22, 2014 1 5 Responsible Authorities: Vice President,

More information

Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs

Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed

More information

Ethics and Bias of Enrolling in Competing Trials: a StrokeNet Survey & Status Update

Ethics and Bias of Enrolling in Competing Trials: a StrokeNet Survey & Status Update Ethics and Bias of Enrolling in Competing Trials: a StrokeNet Survey & Status Update Jennifer Majersik, MD, MS Associate Professor, Neurology, University of Utah For the Committee: Rose Beckmann; Joe Broderick,

More information

COLUMBIA UNIVERSITY INSTITUTIONAL REVIEW BOARD GUIDANCE ON ELECTRONIC INFORMED CONSENT

COLUMBIA UNIVERSITY INSTITUTIONAL REVIEW BOARD GUIDANCE ON ELECTRONIC INFORMED CONSENT COLUMBIA UNIVERSITY INSTITUTIONAL REVIEW BOARD GUIDANCE ON ELECTRONIC INFORMED CONSENT I. BACKGROUND Electronic consenting ( e-consenting ) is the use of electronic systems and processes, whether in person

More information

Reporting to the IRB Part 2

Reporting to the IRB Part 2 Webinar Series Reporting to the IRB Part 2 Frequently Asked Questions December 4, 2013 Presented by: James MacFarlane Director of Board Services About Schulman Associates IRB Established in 1983 US and

More information

Institutional Review Board (IRB) at SMU. Dr. Maribeth Kuenzi, Chair Ms. Shannon Lunt, SMU Director of Research Compliance

Institutional Review Board (IRB) at SMU. Dr. Maribeth Kuenzi, Chair Ms. Shannon Lunt, SMU Director of Research Compliance Institutional Review Board (IRB) at SMU Dr. Maribeth Kuenzi, Chair Ms. Shannon Lunt, SMU Director of Research Compliance slunt@smu.edu 214.768.2029 Permission granted 11/24/14 What does the IRB review?

More information

1/25/2016. Why so many rules? VA Research Website. The website includes information on:

1/25/2016. Why so many rules? VA Research Website.   The website includes information on: VA Portland Health Care System (VAPORHCS) How the VAPORHCS IRB differs from OHSU s Alex Mitchell VA IRB Analyst 503-220-8262 Ext. 54503 January 28, 2016 Why so many rules? Highly Regulated by Congress

More information

New NCCIH Funding Opportunities for Natural Product Clinical Trials. May 9, 2017

New NCCIH Funding Opportunities for Natural Product Clinical Trials. May 9, 2017 New NCCIH Funding Opportunities for Natural Product Clinical Trials May 9, 2017 The Webinar will start at 2:00 p.m. All participants have been placed on mute. We will take questions at the end of the presentation

More information

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 01-12-2018 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices NIH Operates Under a Continuing Resolution

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD

More information

Institutional Review of Research Involving Human Participants. IRB Presentation. University of Central Florida Office of Research & Commercialization

Institutional Review of Research Involving Human Participants. IRB Presentation. University of Central Florida Office of Research & Commercialization Institutional Review of Research Involving Human Participants IRB Presentation University of Central Florida Office of Research & Commercialization 407-823-2901 or fax 407-823-3299 www.research.ucf.edu/compliance/irb.html

More information

IRB, IDEATE, AND HSR. February, 2018 Manuel Gonzalez

IRB, IDEATE, AND HSR. February, 2018 Manuel Gonzalez IRB, IDEATE, AND HSR February, 2018 Manuel Gonzalez Outline What is the IRB? Human Subjects Research and Researcher Responsibilities Citi Certification Ethical Principles Revisions etc. Submitting Studies

More information

Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute

Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute NCI and VA Interagency Group to Accelerate Trials Enrollment (NAVIGATE) Sheila A. Prindiville, M.D.,

More information

The University of British Columbia Board of Governors

The University of British Columbia Board of Governors The University of British Columbia Board of Governors Policy No.: 13 Approval Date: May 1998 Last Revision: June 2014 Responsible Executive: Vice-President Finance Title: Serving and Consumption of Alcohol

More information

IRBMED Seminar Series

IRBMED Seminar Series Seminar Series Revisions to the Federal Policy for the Protection of Human Subjects ('Common Rule') Changes Ahead Scope of the Revisions April 4, 2017 Alisha Bouge, MS, CIP Refresher What is the Common

More information

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017 NCCIH s New Approach to Funding Clinical Trials Informational Webinar April 18, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H., Branch Chief, Clinical Research in Complementary and Integrative Health

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Site Initiation SOP-RES-010 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Rachelle

More information

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/ Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional

More information

Where We Are: NCI s Informed Consent Template and Updates to Address Changing Needs

Where We Are: NCI s Informed Consent Template and Updates to Address Changing Needs Where We Are: NCI s Informed Consent Template and Updates to Address Changing Needs Andrea M. Denicoff, MS, RN Cancer Therapy Evaluation Program Division of Cancer Treatment & Diagnosis November 3, 2016

More information

IRB Policy 5 Research Activities

IRB Policy 5 Research Activities IRB Policy 5: Research Activities Revision Date: April 16, 2008, revision 12/23/09, revised 1/5/2010, revised January 27, 2011, revised January 14, 2016, revised April 2, 2018, revised 9/14/18 I. Definitions:

More information

We are inviting you to participate in a research study/project that has two components.

We are inviting you to participate in a research study/project that has two components. Dear TEACCH Client: One of the missions of the TEACCH Autism Program is to support research on the treatment and cause of autism and related disorders. Therefore, we are enclosing information on research

More information

EXEMPT RESEARCH. Investigators should contact the IRB Office if there are questions about whether an amendment consists

EXEMPT RESEARCH. Investigators should contact the IRB Office if there are questions about whether an amendment consists EXEMPT RESEARCH Introduction Many educational, behavioral, and social science studies present little or no risk to the participants. Likewise, research involving existing data, medical records, and pathologic

More information

VA PERSPECTIVE: CONDUCTING VA/STANFORD COLLABORATIVE PROJECTS

VA PERSPECTIVE: CONDUCTING VA/STANFORD COLLABORATIVE PROJECTS 1 VA PERSPECTIVE: CONDUCTING VA/STANFORD COLLABORATIVE PROJECTS January 2010 Kristin Frazier 493-5000, ext. 67593 Kristin.Frazier@va.gov Collaborative SU-VA Research 2 Long-standing relationship between

More information

We are inviting you to participate in a research study/project that has two components.

We are inviting you to participate in a research study/project that has two components. Dear TEACCH Client: One of the missions of the TEACCH Autism Program is to support research on the treatment and cause of autism and related disorders. Therefore, we are enclosing information on research

More information

ROLE OF PRMS FROM START TO FINISH. Tricia Adrales Bentz, MHA Hollings Cancer Center

ROLE OF PRMS FROM START TO FINISH. Tricia Adrales Bentz, MHA Hollings Cancer Center ROLE OF PRMS FROM START TO FINISH Tricia Adrales Bentz, MHA Hollings Cancer Center National Cancer Institute Designation MUSC-HCC received its NCI designation in 2009. The only NCI designated cancer center

More information

1. What is your role in the AAHRPP accreditation process?

1. What is your role in the AAHRPP accreditation process? Investigator Responsibilities AAHRPP accreditation is a gold standard recognizing adherence to a rigorous set of human subjects protection standards that go beyond federal and state requirements. It communicates

More information

IRB GRAND ROUNDS SOCIAL AND BEHAVIORAL RESEARCH: NEED TO KNOW

IRB GRAND ROUNDS SOCIAL AND BEHAVIORAL RESEARCH: NEED TO KNOW IRB GRAND ROUNDS SOCIAL AND BEHAVIORAL RESEARCH: NEED TO KNOW Vivienne Carrasco, MPH,CIP Senior IRB Regulatory Analyst, Social and Behavioral Sciences Human Subject Research Office University of Miami

More information

FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery

FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery Laura M. Tarantino, Ph.D. Office of Food Additive Safety Center for Food Safety and Applied Nutrition (CFSAN)

More information

Ebola Prevention Vaccine Evaluation in Sierra Leone

Ebola Prevention Vaccine Evaluation in Sierra Leone Ebola Prevention Vaccine Evaluation in Sierra Leone Dr. SAS Kargbo Sierra Leone Ministry of Health and Sanitation Sierra Leone CDC Collaboration World Health Organization, Geneva 9 January 2015 Principal

More information

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES GLOSSARY: Administrative Hold (initiated by the investigator): A voluntary action by the investigator to put research

More information

Department of the Navy Human Research Protection Program

Department of the Navy Human Research Protection Program Department of the Navy Human Research Protection Program Research Involving Human Subjects August 2013 Regulations Four sources: 32 CFR 219 (Common Rule) DoDI 3216.02 SECNAVINST 3900.39D 21 CFR 50 and

More information

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852-1448 September 26, 2011 By Overnight Delivery Michael Dean Berger, M.D.

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Home > Inspections, Compliance, Enforcement, and Criminal Investigations > Enforcement Actions > Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Punjwani, Sohail S., M.D.

More information

Northwestern University Institutional Review Board (IRB)

Northwestern University Institutional Review Board (IRB) Northwestern University Institutional Review Board () Kathleen E. Murphy, PhD, CIP Manager, Social and Behavioral Role in Research The sole mission of the is the protection of humans who participate in

More information

Complementary and Alternative Medicine in Treating Autism Spectrum Disorders. Request for Applications

Complementary and Alternative Medicine in Treating Autism Spectrum Disorders. Request for Applications Complementary and Alternative Medicine in Treating Autism Spectrum Disorders Request for Applications Introduction Although medical care in the United States is increasingly driven by evidence-based practice,

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-13-1-0479 TITLE: Sleep-Disordered Breathing in Chronic SCI: A Randomized Controlled Trial of Treatment Impact on Cognition, Quality of Life, and Cardiovascular Disease PRINCIPAL INVESTIGATOR:

More information

Northwestern University Institutional Review Board (IRB)

Northwestern University Institutional Review Board (IRB) Northwestern University Institutional Review Board () Marcella Oliver Education Specialist Role in Research The sole mission of the is the protection of humans who participate in research.. It is not to

More information

Office of Clinical Research Annual Report 2017 July 1, June 30, 2017

Office of Clinical Research Annual Report 2017 July 1, June 30, 2017 Office of Clinical Research Annual Report 2017 July 1, 2016- June 30, 2017 Table of Contents Title Page Number Mission Statement 1 Objective 1 Research Services 1 Research Highlights 2 Figure 1 Number

More information

The Implications of Modifying Study Eligibility Post-Initiation of Recruitment

The Implications of Modifying Study Eligibility Post-Initiation of Recruitment The Implications of Modifying Study Eligibility Post-Initiation of Recruitment COLLEEN ALLEN, MPH, CCRA THE EMMES CORPORATION THE SOCIETY FOR CLINICAL TRIALS 35 TH ANNUAL MEETING MAY 19, 2014 PHILADELPHIA,

More information

Department of Veterans Affairs (VA): Program in Rehabilitation Research

Department of Veterans Affairs (VA): Program in Rehabilitation Research Department of Veterans Affairs (VA): Program in Rehabilitation Research Overview Funding Opportunities Christopher A. Moore, Ph.D., Dean College of Health and Rehabilitation Sciences: Sargent College Boston

More information

REVIEW MANAGEMENT. Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS

REVIEW MANAGEMENT. Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS REVIEW MANAGEMENT Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS PURPOSE BACKGROUND REFERENCES DEFINITIONS AND ACRONYMS POLICY PROCEDURES EFFECTIVE DATE PURPOSE This MAPP describes: The

More information

Regulatory Considerations for Seamless Oncology Drug Development Expansion Cohorts

Regulatory Considerations for Seamless Oncology Drug Development Expansion Cohorts Regulatory Considerations for Seamless Oncology Drug Development Expansion Cohorts National Cancer Policy Forum - The Drug Development Paradigm in Oncology: Managing Benefit and Risk in Seamless Cancer

More information

Revised Common Rule: Next Steps

Revised Common Rule: Next Steps Revised Common Rule: Next Steps Agenda To what does this Final Rule apply? When does it become effective? How is UM preparing? New and revised definitions Changes to the exempt categories Single IRB review

More information

ARCADIA Study Coordinator Training Investigator Meeting

ARCADIA Study Coordinator Training Investigator Meeting ARCADIA Study Coordinator Training Learning Goals 1. The coordinator will be able to identify the 3 screening tests required to meet the atrial cardiopathy criteria for ARCADIA. 2. The coordinator will

More information

Revised August 28, 2018

Revised August 28, 2018 Florida State University Human Subjects Committee Standard Operational Procedure (SOP) 7-IRB-26 Title: Responsible Executive: Approving Official: Prisoners as Research Subjects Gary K. Ostrander Gary K.

More information

Memorandum of Understanding between the Care Quality Commission and the General Dental Council

Memorandum of Understanding between the Care Quality Commission and the General Dental Council Memorandum of Understanding between the Care Quality Commission and the General Dental Council 1. The purpose of this Memorandum of Understanding (MoU) is to promote patient safety and high quality health

More information

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation Award Number: W81XWH-10-1-0959 TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation PRINCIPAL INVESTIGATOR: Andrea Behrman CONTRACTING

More information

STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA

STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED BY THE NNUH and UEA Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 11 pages Review date November

More information

OHRP Guidance on the Involvement of Prisoners in Research

OHRP Guidance on the Involvement of Prisoners in Research NOTE: THIS GUIDANCE REPLACES THE FOLLOWING OHRP GUIDANCE: "OHRP Guidance on Approving Research Involving Prisoners" (May 19, 2000) found on the OHRP website at: http://ohrp.osophs.dhhs.gov/humansubjects/guidance/prison.htm

More information

8.0 ADVERSE EVENT HANDLING

8.0 ADVERSE EVENT HANDLING 8.0 ADVERSE EVENT HANDLING In accordance with the U.S. Code of Federal Regulations governing IND safety reports (Code of Federal Regulations 21, 312.32), adverse events (AEs) are reported from research

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Burzynski Research Institute

More information

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans AWARD NUMBER: W81XWH-15-1-0005 TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans PRINCIPAL INVESTIGATOR: K. Janet C de Baca CONTRACTING ORGANIZATION:

More information

IRB FREQUENTLY ASKED QUESTIONS. 1. Who must apply for human subjects review through the IRB (Institutional Research Board)?

IRB FREQUENTLY ASKED QUESTIONS. 1. Who must apply for human subjects review through the IRB (Institutional Research Board)? IRB FREQUENTLY ASKED QUESTIONS 1. Who must apply for human subjects review through the IRB (Institutional Research Board)? All Regis University faculty, students (graduate and undergraduate), and staff

More information

REGIS UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS

REGIS UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS IRB Policy November 1, 2015 REGIS UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS 1 TABLE OF CONTENTS I. Introduction... 5 A. General Distribution of Responsibility....

More information

Data Quality and Medical Record Abstraction in the Veterans Health Administration s External Peer Review Program

Data Quality and Medical Record Abstraction in the Veterans Health Administration s External Peer Review Program Data Quality and Medical Record Abstraction in the Veterans Health Administration s External Peer Review Program (Practice-oriented paper) James H. Forsythe, PhD Epidemiologist, West Virginia Medical Institute

More information

Human Research Participant Protection Program

Human Research Participant Protection Program Human Research Participant Protection Program Guidance on IRB Review of International Research Issued: 6/3/14 I. Subject: Research conducted by Cornell University investigators outside of the United States

More information

Protecting Human Subjects In Social-Behavioral-Educational Research:

Protecting Human Subjects In Social-Behavioral-Educational Research: Protecting Human Subjects In Social-Behavioral-Educational Research: Working with the IRB Lloyd Byrd, MS Chair, VCU IRB Panel E Member, VCU IRB Panel B Monika S. Markowitz, Ph.D. Director, Office of Research

More information

Successful collaboration for research development between the NIH and patient organisations

Successful collaboration for research development between the NIH and patient organisations Successful collaboration for research development between the NIH and patient organisations Stephen C. Groft, Pharm.D. Office of Rare Diseases s of Health Department of Health and Human Services EURORDIS

More information

11/11/14. Clinical Research Panel. Barriers to multi-site collaborations. Definition: Common Data Elements

11/11/14. Clinical Research Panel. Barriers to multi-site collaborations. Definition: Common Data Elements Barriers to multi-site collaborations A case for common data elements (CDE) Clinical Research Panel 4:40-4.46 Introduction: Who needs CDEs? Winstein 4:47 4:53 CDE databases-what s out there? Plummer Who

More information

RSC Approval of CHR Studies Involving Radiation Exposure to Human Subjects

RSC Approval of CHR Studies Involving Radiation Exposure to Human Subjects RSC Approval of CHR Studies Involving Radiation Exposure to Human Subjects NOTE: Any questions may be directed to the Technical Committees Coordinator or EH&S Radiation Safety at chr.rsc.coordinator@ucsf.edu

More information

Protection of Human Subjects Policies and Procedures

Protection of Human Subjects Policies and Procedures Protection of Human Subjects Policies and Procedures Introduction Wilmington University has a functioning committee and procedures to review and approve all research involving human subjects. All human

More information

UNITED STATES SENATE COMMITTEE ON VETERANS AFFAIRS HEARING ON MAKING THE VA THE WORKPLACE OF CHOICE FOR HEALTH CARE PROVIDERS

UNITED STATES SENATE COMMITTEE ON VETERANS AFFAIRS HEARING ON MAKING THE VA THE WORKPLACE OF CHOICE FOR HEALTH CARE PROVIDERS UNITED STATES SENATE COMMITTEE ON VETERANS AFFAIRS HEARING ON MAKING THE VA THE WORKPLACE OF CHOICE FOR HEALTH CARE PROVIDERS Testimony of Randy Phelps, Ph.D. Deputy Executive Director for Professional

More information

This SOP applies to all IRB administrative staff, members and investigators. IRB members, administrative staff and investigators.

This SOP applies to all IRB administrative staff, members and investigators. IRB members, administrative staff and investigators. UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD INFORMED CONSENT OF NON-ENGLISH SPEAKING SUBJECTS, ILLITERATE ENGLISH-SPEAKING SUBJECTS, AND VISUALLY- IMPAIRED OR HEARING-IMPAIRED

More information

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-14-1-0503 TITLE: Effect of Diabetes and Obesity on Disparities in Prostate Cancer Outcomes PRINCIPAL INVESTIGATOR: Bettina F. Drake, MPH, PhD CONTRACTING ORGANIZATION: Washington University

More information

INSTITUTIONAL REVIEW BOARD

INSTITUTIONAL REVIEW BOARD INSTITUTIONAL REVIEW BOARD Policies and Definitions promotes and supports human research. Basic tenets of human research are voluntary participation and the ethical treatment of the subjects in the research

More information

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-14-1-0503 TITLE: Effect of Diabetes and Obesity on Disparities in Prostate Cancer Outcomes PRINCIPAL INVESTIGATOR: Bettina F. Drake, MPH, PhD CONTRACTING ORGANIZATION: Washington University

More information

EPA REGULATORY UPDATE

EPA REGULATORY UPDATE SOCIETY OF QUALITY ASSURANCE REGULATORY FORUM EPA REGULATORY UPDATE Linthicum Heights, Maryland January 24, 2008 Robert Cypher United States Environmental Protection Agency 2/13/2008 SQA Baltimore 1 ANY

More information

Scientific Misconduct September 15, Presented by May Al Kassar

Scientific Misconduct September 15, Presented by May Al Kassar Research Non-Compliance & Scientific Misconduct September 15, 2010 Presented by May Al Kassar Responsible Research Conduct The ethical conduct of research is a shared responsibility among: The institution

More information

NIH Biographical Sketches: Discussing the New Format

NIH Biographical Sketches: Discussing the New Format NIH Biographical Sketches: Discussing the New Format February 23, 2015 Joann Sullivan, PhD Director, Office of Research Development 1 NIH Biographical Sketches Biosketch format that must be used for due

More information

Approved for public release; distribution unlimited

Approved for public release; distribution unlimited Award Number: W81XWH-16-1-0763 TITLE: Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy PRINCIPAL INVESTIGATOR: Thomas J. Schnitzer,

More information

Sleep for Stroke Management And Recovery Trial NINDS U01NS StrokeNet Meeting October 16, 2018

Sleep for Stroke Management And Recovery Trial NINDS U01NS StrokeNet Meeting October 16, 2018 Sleep for Stroke Management And Recovery Trial NINDS U01NS099043 StrokeNet Meeting October 16, 2018 Study Team Key roles: Project PIs: Devin Brown, Ronald Chervin UM Project Manager: Kayla Gosselin NCC:

More information

RESEARCH GRANT APPLICATION

RESEARCH GRANT APPLICATION 2018-2019 RESEARCH GRANT APPLICATION Deadline: Friday, December 8, 2017 Osseointegration Foundation Research Grants The object of these grants is to provide funding for basic and applied scientific research

More information

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY August 24, 2012 1. Purpose Public confidence and the reputation of the company are valuable business assets that Inovio strives to

More information

STRESS Trial: Steroids to Reduce Systemic inflammation after Neonatal Heart Surgery

STRESS Trial: Steroids to Reduce Systemic inflammation after Neonatal Heart Surgery STRESS Trial: Steroids to Reduce Systemic inflammation after Neonatal Heart Surgery Leveraging Existing Resources to Improve Clinical Trials U01 TR001803-01 Duke University (Jennifer S. Li, Kevin D. Hill)

More information

2018 CTMC Faculty Harold Adams, MD, FAAN Ken Cheung, PhD Christopher S. Coffey, PhD

2018 CTMC Faculty Harold Adams, MD, FAAN Ken Cheung, PhD Christopher S. Coffey, PhD Harold Adams, MD, FAAN Harold Adams, Jr., MD is a professor of neurology in the Carver College of Medicine at the University of Iowa. He has been active in patient care and clinical research that has focused

More information